Attorneys agree that FTC's announced settlements with personal-care companies for misleading "all-natural" claims likely will not be helpful to class-action defendants making primary-jurisdiction arguments and could actually spur more litigation, similar to trends following FDA warning letters.
The Federal Trade Commission's crackdown on fraudulent "all-natural" claims in the personal-care space is not likely to undermine pending class actions or curtail litigation. In fact, it could encourage more suits, attorneys suggest.
The agency announced proposed settlements April 12 with four companies for all-natural and 100% natural claims in online advertising for personal-care products that in reality contained synthetic ingredients, as well as a fifth complaint against a purported
Firms in the US facing tariff costs should identify US-based, non-tariff sources and lobby local government officials and DC when foreign-sourced ingredients cannot be substituted in the US.
By guiding regulators through case studies and mock dossier examples of how to utilize new approach methodologies, the International Collaboration on Cosmetics Safety hopes to counter hesitations in replacing animal tests.
The US Food and Drug Administration has released a roadmap to adopt new approach methodologies in lieu of animal testing for monoclonal antibody therapies and other drugs, which may include OTC drugs though the proposal does not specifically include cosmetics.
